BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Business

  King Pharmaceuticals®, Inc. Posts Net Loss, but Results Beat Street

  May 11, 2009

   · 

  1 min read
• Business

  Ceragenix Pharmaceuticals, Inc. Enters into Second Exclusive Option to License Agreement for Antimicrobial Medical Device

  May 11, 2009

   · 

  4 min read
• FDA

  FDA Approves GlaxoSmithKline’s Lamictal(R) ODT(TM) Orally Disintegrating Tablets

  May 11, 2009

   · 

  7 min read
• Drug Development

  Targacept, Inc. Announces Positive Top-Line Results From Phase II Study of AZD3480 in Adult ADHD

  May 11, 2009

   · 

  1 min read
• Warner Chilcott Proposes Redomestication From Bermuda to Ireland

  May 11, 2009

   · 

  6 min read
• Business

  Warner Chilcott Q1 Results Miss Street; Backs ’09 View

  May 11, 2009

   · 

  16 min read
• Business

  Logical Therapeutics, Inc. Appoints Peter A. Lankau as CEO and Director

  May 11, 2009

   · 

  4 min read
• Drug Development

  Quark Pharmaceuticals Inc. Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3

  May 11, 2009

   · 

  4 min read
• Business

  Orexigen Therapeutics, Inc. Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy

  May 11, 2009

   · 

  5 min read
• Pharm Country

  Amicus Therapeutics, Inc. to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

  May 11, 2009

   · 

  1 min read